Fundraising Fox

Biotech Late Stage Investors & VC Firms

652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.

Atlantic Bridge Ventures
DublinSeed–Late Stage$1M – $5M
41 people
Cerity Partners Ventures
BostonSeed–Late Stage
20 people
Giant Ventures Global Llp
LondonPre-Seed–Late Stage$10M – $20M
31 people
WCAS
New YorkGrowth–Late Stage
49 people
Atlas Venture
CambridgeSeed–Late Stage$500K – $1M
29 people
Metaplanet
TallinnSeed–Late Stage$500K – $10M
6 people
Hercules Capital, Inc.
San MateoSeed–Late Stage$5M – $500M
56 people
Kiwoom Investment
SeoulSeed–Late Stage
Optum Ventures
BostonSeed–Late Stage
35 people
OUP (Osage University Partners)
Bala CynwydPre-Seed–Late Stage$1M – $20M
23 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
22 people
Eight Roads Ventures
MumbaiSeed–Late Stage$5M – $30M
20 people
Korys
HalleSeries A–Late Stage$5.4M
40 people
Vida Ventures
Los AngelesPre-Seed–Late Stage
43 people
LIFTT
TorinoPre-Seed–Late Stage
36 people
Pappas Capital
DurhamPre-Seed–Late Stage
34 people
Lightstone Ventures
Portola ValleyPre-Seed–Late Stage
32 people
Olive Tree Capital
BostonSeed–Late Stage
5 people
US Venture Partners
Menlo ParkSeed–Late Stage$500K – $10M
9 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
45 people
Illumina Ventures
Foster CityPre-Seed–Late Stage
41 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
42 people
Advent Life Sciences
LondonSeed–Late Stage
29 people
Capricorn Venture Partners
LeuvenSeed–Late Stage$270K – $10.8M
30 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.